Senior insider sale
AVALO THERAPEUTICS, INC. — senior position signals high conviction
$51.5K
3.17K shares
What this filing means
CHAN MITCHELL plans to sell 3.17K shares of AVALO THERAPEUTICS, INC. valued at approximately $51.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001950047-26-004138
3.17K
Shares to sell
$51.5K
Approx. market value
3.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/28/2025
3.17KTotal acquired3.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/28/2025 | Restricted Stock Units N/A | 3.17K | — |
| Total | 3.17K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.17K
Market value
$51.5K
5/6/2026
Total
Units
3.17K
Value
$51.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/6/2026 | 3.17K | $51.5K | NASDAQ | Planned |
| Total | 3.17K | $51.5K | ||